DE3481511D1 - 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor. - Google Patents

2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor.

Info

Publication number
DE3481511D1
DE3481511D1 DE8484113600T DE3481511T DE3481511D1 DE 3481511 D1 DE3481511 D1 DE 3481511D1 DE 8484113600 T DE8484113600 T DE 8484113600T DE 3481511 T DE3481511 T DE 3481511T DE 3481511 D1 DE3481511 D1 DE 3481511D1
Authority
DE
Germany
Prior art keywords
substituted
cor
chem
pyrryl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484113600T
Other languages
German (de)
English (en)
Inventor
Tesfaye Biftu
San-Bao Hwang
Thomas W Doebber
Thomas R Beattie
Tsung-Ying Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3481511D1 publication Critical patent/DE3481511D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE8484113600T 1983-11-14 1984-11-12 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor. Expired - Fee Related DE3481511D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/551,666 US4539332A (en) 1983-11-14 1983-11-14 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists

Publications (1)

Publication Number Publication Date
DE3481511D1 true DE3481511D1 (de) 1990-04-12

Family

ID=24202197

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484113600T Expired - Fee Related DE3481511D1 (de) 1983-11-14 1984-11-12 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor.

Country Status (8)

Country Link
US (1) US4539332A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0144804B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS60116679A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE50768T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1267417A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3481511D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK538384A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8606318A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619943A (en) * 1981-06-04 1986-10-28 Rao Koppaka V Neolignans of Saururus cernuus L and analogues thereof
US5010100A (en) * 1983-11-14 1991-04-23 Merck & Co. Inc. Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
JPS61212518A (ja) * 1985-03-19 1986-09-20 Nippon Paint Co Ltd 血液凝固促進剤
NZ215866A (en) * 1985-04-22 1989-11-28 Merck & Co Inc 2,5-di(aryl/heterocyclyl) tetrahydro-furans and pharmaceutical compositions
DE3778248D1 (de) * 1986-08-21 1992-05-21 Merck & Co Inc 1,3-diarylcyclopentane und deren abkoemmlinge als paf-antagonisten.
US4879285A (en) * 1986-08-22 1989-11-07 Royal North Shore Hospital And Area Health Service Fertility control
PH23898A (en) * 1986-09-12 1989-12-18 Duphar Int Res New phenyl pyrrolidin-2-yl substituted-2-yl substituted 5-ring heterocycles having antipsycotic properties
GB2197650A (en) * 1986-11-21 1988-05-25 Merck & Co Inc Process for preparing 2,5-diphenyl tetrahydrofurans and analogs thereof
NZ227287A (en) * 1987-12-21 1992-01-29 Merck & Co Inc 2,5-diaryl tetrahydrofurans and medicaments
US4996203A (en) * 1987-12-21 1991-02-26 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5334592A (en) * 1988-04-27 1994-08-02 Schering Corporation Certain PAF antagonist antihistamine combinations and methods
JPH0655673B2 (ja) * 1988-04-27 1994-07-27 シェリング・コーポレーション Ｐａｆ拮抗薬‐抗ヒスタミン剤の組合せ及び使用方法
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
US5114961A (en) * 1989-06-08 1992-05-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US4977146A (en) * 1989-06-08 1990-12-11 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5011847A (en) * 1989-06-08 1991-04-30 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
US5001123A (en) * 1989-06-08 1991-03-19 Merck & Co., Inc. 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
DE4014420A1 (de) * 1989-09-23 1991-04-04 Bayer Ag 5h-furan-2-on-derivate
GB9009469D0 (en) * 1990-04-27 1990-06-20 British Bio Technology Compounds
US5099033A (en) * 1990-06-29 1992-03-24 Merck & Co., Inc. Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as PAF antagonists
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides
PT98674B (pt) * 1990-08-15 1999-01-29 British Bio Technology Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de imidazole e de seus intermedriarios
EP0574510B1 (en) * 1991-03-04 2001-09-05 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
GB9104746D0 (en) * 1991-03-06 1991-04-17 British Bio Technology Compounds
GB9114337D0 (en) * 1991-07-03 1991-08-21 British Bio Technology Compounds
GB9116056D0 (en) * 1991-07-24 1991-09-11 British Bio Technology Compounds
GB9122308D0 (en) * 1991-10-21 1991-12-04 British Bio Technology Compounds
GB9200209D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5463083A (en) 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
DE69329550T2 (de) 1992-07-13 2001-05-31 Cytomed, Inc. 2,5-diaryl tetrahydro-thiopene, -furane und analoge zur behandlung von entzündungs-und immunkrankheiten
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
KR960700045A (ko) * 1993-01-11 1996-01-19 가자마 하치자에몽 혈관신생 저해제 및 신규 화합물
US6492413B2 (en) 1993-01-15 2002-12-10 G.D. Searle & Co. 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
YU66700A (sh) * 1998-05-01 2003-01-31 Kyoto Pharmaceutical Industries Ltd. Derivati karbapenema, njihovo korišćenje i intermedijarna jedinjenja istih
US20240065809A1 (en) 2020-12-30 2024-02-29 3M Innovative Properties Company Bondable orthodontic assemblies and methods for bonding

Also Published As

Publication number Publication date
JPH0550516B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-07-29
DK538384A (da) 1985-06-19
US4539332A (en) 1985-09-03
EP0144804B1 (en) 1990-03-07
ATE50768T1 (de) 1990-03-15
EP0144804A3 (en) 1986-01-08
ES8606318A1 (es) 1986-04-16
DK538384D0 (da) 1984-11-13
ES537583A0 (es) 1986-04-16
CA1267417A (en) 1990-04-03
JPS60116679A (ja) 1985-06-24
EP0144804A2 (en) 1985-06-19

Similar Documents

Publication Publication Date Title
DE3481511D1 (de) 2,5-diaryltetrahydrofurane und analoge davon als antagonisten fuer thrombozyten aktivierenden faktor.
ES2002312A6 (es) Procedimiento para la preparacion de nuevos 2,5-doaril-tetrahiodrotiofenos y analogos de los mismos, utiles ccomo antagonistas del fap.
IL72120A (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
HUT58760A (en) Process for produicng compounds of fibrinogene-receptor antagonistic activity and pharmaceutical compositions containing them
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
IT1210589B (it) Procedimento per la preparazione dicomposti pirimidinici dotati di attivita' farmacologica particolarmente per il trattamento di infezioni batteriche loro intermedi prodotto ottenuto e composizioni farmaceutiche che li contengono
FR2391209A1 (fr) Aminoalkyl thiophenes, utiles comme medicaments, leur preparation et compositions en contenant
SE8500460L (sv) Nya 6-substituerade furo-(3,4-c)-pyridin-derivat, sett for deras framstellning och terapeutiska kompositioner, innehallande foreningarna
EP0322033A3 (en) New 2,5-diaryl tetrahydrofurans and analogs thereof as paf antagonists
ES8607274A1 (es) Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos.
IL64472A0 (en) Pharmaceutical compositions containing tricyclic cytosin derivatives,certain new compounds of this class and their production
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
DK0441279T3 (da) Bilobalid-phospholipid-komplekser, deres anvendelse og sammensætninger, der indeholder dem
IT1171477B (it) Derivati del 4h-1,2,4-triazolo procedimento per la loro preparazione, loro impiego in quanto farmaci, composizioni che li contengono e prodotti intermedi ottenuti
DK165157C (da) Phosphatidholdigt insekticidt praeparat, dets fremstilling og anvendelse
FI844232L (fi) Purinderivat.
ATE3639T1 (de) Antiallergische imidodisulfamide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
IT1138155B (it) Composti citostatici,procedimento per la loro preparazione e composizioni farmaceutiche contenenti gli stessi
IT1251702B (it) Complessi del ferro con la conalbumina e i suoi derivati
DK165100C (da) Phosphatidholdigt, fungicidt praeparat, dets fremstilling og anvendelse
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
IT7950049A0 (it) Derivati acetilenici dell'androst-4-ene,procedimento per la loro produzione,loro impiego come medicamenti e composizioni farmaceutiche che licontengono
IT1168171B (it) Derivati del 2-idrossimetil-chinossalin-1,4-biossido, procedimento per la loro preparazione e composizioni contenenti gli stessi
IT1150024B (it) 4-fenil-4,5,6,7-tetraidropirrolo(2,3-c) piridine,procedimento per la loro fabbricazione,nonche'composizioni farmaceutiche relative
CA159452A (en) Child's pants

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee